Literature DB >> 25456020

Re: "Early benefit assessment of new drugs in Germany--results from 2011 to 2012" [Health Policy 116 (2-3) (2014) 147-153].

Tina Orben1, Andrej Rasch2, Charalabos-Markos Dintsios2.   

Abstract

Mesh:

Year:  2014        PMID: 25456020     DOI: 10.1016/j.healthpol.2014.10.009

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


× No keyword cloud information.
  1 in total

1.  Benefit assessment in Germany: implications for price discounts.

Authors:  Ulrike Theidel; J-Matthias Graf von der Schulenburg
Journal:  Health Econ Rev       Date:  2016-08-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.